Postinduction Carbamazepine Clearance in an Adult Psychiatric Population
暂无分享,去创建一个
M L Crismon | P. Godley | P J Godley | M. L. Crismon | E S Martin | E. Martin | M. Lynn Crismon | Paul J. Godley
[1] A. Frigerio,et al. Carbamazepine: biotransformation. , 1975, Advances in neurology.
[2] R. Post,et al. Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite. , 1984, Acta psychiatrica Scandinavica. Supplementum.
[3] R. Post,et al. Antidepressant effects of carbamazepine. , 1986, The American journal of psychiatry.
[4] A. Kazdin,et al. Carbamazepine and Behavior Therapy for Aggressive Behavior , 1983, Behavior modification.
[5] J. Hull,et al. The Effect of Disease States on Drug Pharmacokinetics , 1977 .
[6] J. Boelaert,et al. Should clearance be normalised to body surface or to lean body mass? , 1981, British journal of clinical pharmacology.
[7] R. Post,et al. Carbamazepine in manic-depressive illness: a new treatment. , 1980, The American journal of psychiatry.
[8] R. Post,et al. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. , 1983, Archives of general psychiatry.
[9] R. Summers,et al. Carbamazepine Clearance in Paediatric Epilepsy Patients , 1989, Clinical pharmacokinetics.
[10] W. Petrie,et al. Carbamazepine treatment of selected affectively disordered inpatients. , 1982, The American journal of psychiatry.
[11] Tw. Rall,et al. Drugs effective in the therapy of the epilepsies , 1985 .
[12] A. Kumps. Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy. , 1981, Therapeutic drug monitoring.